Assembly Biosciences Statistics
Total Valuation
ASMB has a market cap or net worth of $92.67 million. The enterprise value is $5.41 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ASMB has 7.50 million shares outstanding. The number of shares has increased by 33.26% in one year.
Current Share Class | 7.50M |
Shares Outstanding | 7.50M |
Shares Change (YoY) | +33.26% |
Shares Change (QoQ) | +14.86% |
Owned by Insiders (%) | 10.53% |
Owned by Institutions (%) | 14.48% |
Float | 4.50M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.48 |
Forward PS | 2.86 |
PB Ratio | 3.44 |
P/TBV Ratio | 3.44 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.17 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.11.
Current Ratio | 2.05 |
Quick Ratio | 1.95 |
Debt / Equity | 0.11 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -133.65% and return on invested capital (ROIC) is -86.24%.
Return on Equity (ROE) | -133.65% |
Return on Assets (ROA) | -25.49% |
Return on Invested Capital (ROIC) | -86.24% |
Return on Capital Employed (ROCE) | -85.20% |
Revenue Per Employee | $440,466 |
Profits Per Employee | -$546,822 |
Employee Count | 73 |
Asset Turnover | 0.29 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ASMB has paid $330,000 in taxes.
Income Tax | 330,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.84% in the last 52 weeks. The beta is 0.50, so ASMB's price volatility has been lower than the market average.
Beta (5Y) | 0.50 |
52-Week Price Change | -7.84% |
50-Day Moving Average | 10.77 |
200-Day Moving Average | 14.26 |
Relative Strength Index (RSI) | 57.75 |
Average Volume (20 Days) | 19,009 |
Short Selling Information
The latest short interest is 13,209, so 0.18% of the outstanding shares have been sold short.
Short Interest | 13,209 |
Short Previous Month | 18,615 |
Short % of Shares Out | 0.18% |
Short % of Float | 0.29% |
Short Ratio (days to cover) | 0.50 |
Income Statement
In the last 12 months, ASMB had revenue of $32.15 million and -$39.92 million in losses. Loss per share was -$6.13.
Revenue | 32.15M |
Gross Profit | -23.78M |
Operating Income | -44.63M |
Pretax Income | -45.17M |
Net Income | -39.92M |
EBITDA | -44.50M |
EBIT | -44.63M |
Loss Per Share | -$6.13 |
Full Income Statement Balance Sheet
The company has $91.03 million in cash and $3.02 million in debt, giving a net cash position of $88.01 million or $11.73 per share.
Cash & Cash Equivalents | 91.03M |
Total Debt | 3.02M |
Net Cash | 88.01M |
Net Cash Per Share | $11.73 |
Equity (Book Value) | 27.13M |
Book Value Per Share | 3.56 |
Working Capital | 48.90M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$56.19 million and capital expenditures -$14,000, giving a free cash flow of -$56.21 million.
Operating Cash Flow | -56.19M |
Capital Expenditures | -14,000 |
Free Cash Flow | -56.21M |
FCF Per Share | -$7.49 |
Full Cash Flow Statement Margins
Gross margin is -73.95%, with operating and profit margins of -138.81% and -124.15%.
Gross Margin | -73.95% |
Operating Margin | -138.81% |
Pretax Margin | -123.12% |
Profit Margin | -124.15% |
EBITDA Margin | -138.40% |
EBIT Margin | -138.81% |
FCF Margin | n/a |
Dividends & Yields
ASMB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -33.26% |
Shareholder Yield | -33.26% |
Earnings Yield | -42.73% |
FCF Yield | -60.17% |
Analyst Forecast
The average price target for ASMB is $33.00, which is 167.21% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $33.00 |
Price Target Difference | 167.21% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 6.05% |
EPS Growth Forecast (5Y) | 3.46% |
Stock Forecasts Stock Splits
The last stock split was on February 12, 2024. It was a reverse split with a ratio of 0.0833333:1.
Last Split Date | Feb 12, 2024 |
Split Type | Reverse |
Split Ratio | 0.0833333:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |